1.Gastrointestinal stromal tumor with a new concept and promising treatment.
Korean Journal of Medicine 2002;63(1):4-6
No abstract available.
Gastrointestinal Stromal Tumors*
2.Oncologic Outcome of Chondrosarcomas.
Chol Jin KIM ; Jun Young CHUNG ; Yang Guk CHUNG ; Seung Koo RHEE ; Yong Koo KANG ; Won Jong BAHK ; Jung In SHIM
The Journal of the Korean Bone and Joint Tumor Society 2013;19(1):9-13
PURPOSE: We evaluated oncologic outcomes of chondrosarcomas and analyzed the disease-free survival rate of chondrosarcomas according to the various factors. MATERIALS AND METHODS: We performed a retrospective study for the disease-free survival rate of 48 chondrosarcomas, 44 of which underwent surgical treatment and followed up more than 18 months since 1993, and in the remaining 4 cases, the patients died before 18 months after surgery. The vsariables were location, tumor volume, histologic grade, stage, age at presentation and treatment performed. The mean follow up period was 43.8 months (1-196 months). RESULTS: The overall disease-free survival rate was 77.1% at mean 43.8 month follow up. The 5 year- and 10 year disease-free survival rates were 64% and 58% respectively. The histologic grade, stage, age at presentation revealed statistical significance on disease-free survival. All 9 patients treated with extended curettage for grade 1 central chondrosarcomas revealed disease-free survival with excellent functional outcome. CONCLUSION: The disease-free survival rate of chondrosarcomas mainly depended on histologic grade, stage and age at presentation. Local recurrence and distant metastasis also revealed statistically significant differences of disease-free survival rate. Comparing to wide resection, extended curettage for low-grade central chondrosarcomas in extremities were efficient methods with similar survival rate and less functional losses and complications.
Chondrosarcoma
;
Curettage
;
Disease-Free Survival
;
Extremities
;
Follow-Up Studies
;
Humans
;
Neoplasm Metastasis
;
Recurrence
;
Retrospective Studies
;
Survival Rate
;
Tumor Burden
3.The Use of Lung Ultrasound in a Surgical Intensive Care Unit.
Hyung Koo KANG ; Hyo Jin SO ; Deok Hee KIM ; Hyeon Kyoung KOO ; Hye Kyeong PARK ; Sung Soon LEE ; Hoon JUNG
Korean Journal of Critical Care Medicine 2017;32(4):323-332
BACKGROUND: Pulmonary complications including pneumonia and pulmonary edema frequently develop in critically ill surgical patients. Lung ultrasound (LUS) is increasingly used as a powerful diagnostic tool for pulmonary complications. The purpose of this study was to report how LUS is used in a surgical intensive care unit (ICU). METHODS: This study retrospectively reviewed the medical records of 67 patients who underwent LUS in surgical ICU between May 2016 and December 2016. RESULTS: The indication for LUS included hypoxemia (n = 44, 65.7%), abnormal chest radiographs without hypoxemia (n = 17, 25.4%), fever without both hypoxemia and abnormal chest radiographs (n = 4, 6.0%), and difficult weaning (n = 2, 3.0%). Among 67 patients, 55 patients were diagnosed with pulmonary edema (n = 27, 41.8%), pneumonia (n = 20, 29.9%), diffuse interstitial pattern with anterior consolidation (n = 6, 10.9%), pneumothorax with effusion (n = 1, 1.5%), and diaphragm dysfunction (n = 1, 1.5%), respectively, via LUS. LUS results did not indicate lung complications for 12 patients. Based on the location of space opacification on the chest radiographs, among 45 patients with bilateral abnormality and normal findings, three (6.7%) and two (4.4%) patients were finally diagnosed with pneumonia and atelectasis, respectively. Furthermore, among 34 patients with unilateral abnormality and normal findings, two patients (5.9%) were finally diagnosed with pulmonary edema. There were 27 patients who were initially diagnosed with pulmonary edema via LUS. This diagnosis was later confirmed by other tests. There were 20 patients who were initially diagnosed with pneumonia via LUS. Among them, 16 and 4 patients were finally diagnosed with pneumonia and atelectasis, respectively. CONCLUSIONS: LUS is useful to detect pulmonary complications including pulmonary edema and pneumonia in surgically ill patients.
Anoxia
;
Critical Care*
;
Critical Illness
;
Diagnosis
;
Diaphragm
;
Fever
;
Humans
;
Lung*
;
Medical Records
;
Pneumonia
;
Pneumothorax
;
Pulmonary Atelectasis
;
Pulmonary Edema
;
Radiography, Thoracic
;
Retrospective Studies
;
Ultrasonography*
;
Weaning
4.Survival Rate after Pulmonary Metastasectomy in Bone and Soft Tissue Sarcoma.
Yong Koo KANG ; Seung Koo LEE ; Jung Man KIM ; Hoon Kyo KIM ; Kun Hyun CHO ; Young Hoon KIM
The Journal of the Korean Orthopaedic Association 1997;32(1):223-228
We investigated the overall survival rate after pulmonary metastasectomy in the bone and soft tissue sarcoma and the available prognostic factors related with the survival rate after pulmonary metastasectomy. Between 1986 and 1995, 9 patients (median age 32) with bone and soft tissue sarcoma with pulmonary metastasis were managed in the Catholic University of Korea. Until the final follow-up in May 1996, 6 patients have died of disease and their mean survival period was 28 months (9- 58months). The actual 5-year survival rate by Kaplan-Meier method was 33%. Prognostic factors such as tumor free interval, number of metastatic lesion, postoperative chemotherapy and histologic grade were analyzed. Three patients who had the tumor free interval over 3 years were alive (mean survival period: 52.6 months), whereas six patients who had the tumor free interval less than 3 years were dead (mean survival period: 19 months). Out of four patients with low grade tumor, three patients were alive with average 39.2 months survival period, whereas five patients with high grade tumor were all dead with average 19.2 months survival period. These results suggested that pulmonary metastasectomy in bone and soft tissue sarcoma may prolong the survival rate. The long tumor free interval, histological low grade and soft tissue sarcoma may influenced on prolonged survival rate. However, number of metastatic lesion or postoperative chemotherapy has not influenced on the survival rate.
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Korea
;
Metastasectomy*
;
Neoplasm Metastasis
;
Sarcoma*
;
Survival Rate*
5.Secondary Chondrosarcoma Arising from Osteochondroma(tosis).
Hyun min CHO ; Seung Koo RHEE ; Yong Koo KANG ; Yang Guk CHUNG ; An Hi LEE ; Jung Mi PARK ; Won Jong BAHK
The Journal of the Korean Bone and Joint Tumor Society 2010;16(1):21-26
PURPOSE: To analyze clinical, radiological and pathological features as well as clinical outcome after surgical treatment of patients with secondary chondrosarcoma arising from osteochondroma(tosis). MATERIALS AND METHODS: We retrospectively reviewed clinical records, radiographs, pathologic slides of 14 patients. Nine patients were male and five were female. The mean age was 34 years. The mean follow-up period was 54 months. RESULTS: All patients had a history of previous mass since childhood or puberty. Preexisted osteochondroma was single in 3 patients and multiple in 10. Remaining 1 patient had multiple osteochondromatosis with enchondromatosis. MRI clearly provided thickness of cartilage cap, which was over 2 cm except in 2 cases. Chondrosarcoma was grade 1 in all except 1 case, which was grade 2. Wide excision was performed in 10 patients, marginal excision in 3 and amputation in 1. Twelve patients were doing very well without evidence of disease. Among 3 patients with marginal excision, 1 patient had local recurrence and 1 patient died of disease. CONCLUSION: Comprehensive understanding of clinical, radiological and pathological features of secondary chondrosarcoma is warranted for accurate diagnosis. The best result can be expected with early recognition of malignant change of osteohcondroma(tosis) and wide excision.
Amputation
;
Cartilage
;
Chondrosarcoma
;
Enchondromatosis
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Osteochondroma
;
Osteochondromatosis
;
Puberty
;
Recurrence
;
Retrospective Studies
6.Prognostic Factors in Liposarcomas: A Retrospective Study of 52 Patients.
Yang Guk CHUNG ; Yong Koo KANG ; Won Jong BAHK ; Seung Koo RHEE ; An Hi LEE ; Jung Mee PARK ; Min Woo KIM
The Journal of the Korean Bone and Joint Tumor Society 2010;16(1):14-20
PURPOSE: To investigate prognostic factors influencing on local recurrence, distant metastasis and event-free survival of liposarcomas. MATERIALS AND METHODS: Fifty-two patients managed for liposarcomas since 1993 were analyzed respectively in the view of prognostic influence of patient age, tumor size, location, histologic type, histologic grade, resection type, surgical margin, chemotherapy and radiation therapy on local recurrence, distant metastasis and event-free survival. The mean follow up period was 39 months. The univariate and multivariate regression analysis were performed for statistical evaluation. RESULTS: The local recurrences occurred in 11 patients (21.2%) and distant metastasis in 4 patients (8%), Event-free survival rate at 4 year follow up was 67%. In univariate analysis, histologic grade, surgical margin, chemotherapy and radiation therapy were significant prognostic factors on local recurrence (p<0.05). However, histologic grade lost its significance in muitivariate analysis. Trunk location revealed higher rate of distant metastasis than extremity location. In univariate analysis on event-free survival. histologic grade and chemotherapy were significant factors (p<0.05). No factor remained significant in multivariate analysis. CONCLUSION: Considering selection bias, positive surgical margin was negative prognostic factor on local recurrence. Liposarcomas arisen in trunk revealed higher rate of distant metastasis. There was no independent prognostic factor on event-free survival of patients with liposarcomas.
Disease-Free Survival
;
Extremities
;
Follow-Up Studies
;
Humans
;
Liposarcoma
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Recurrence
;
Retrospective Studies
;
Selection Bias
7.The clinical case report of echinococcal cyst of the liver caused by echinococcus granulous.
Dong Jin KIM ; Koo Jung KANG ; Yong Kee PARK ; Chang Rock CHOI
Journal of the Korean Surgical Society 1993;44(5):758-766
No abstract available.
Echinococcus*
;
Liver*
8.Short-term and intermediate-term follow-up after valve replacement with the St. Jude Medical prosthesis.
Bum Koo CHO ; Byung Chul CHANG ; Meyun Shick KANG ; Jung Hyun BANG ; Sung Nok HONG
The Korean Journal of Thoracic and Cardiovascular Surgery 1992;25(1):57-65
No abstract available.
Follow-Up Studies*
;
Prostheses and Implants*
9.Posterior left ventricular wall rupture after mitral valve replacement.
Meyun Shick KANG ; Dong Moon SOH ; Suk Jung CHOO ; Bum Koo CHO
The Korean Journal of Thoracic and Cardiovascular Surgery 1992;25(11):1254-1260
No abstract available.
Mitral Valve*
;
Rupture*
10.Ovarian Paragonimiasis: A case report.
Shin Mong KANG ; Yong Koo PARK ; Ju Hie LEE ; Jung Eun MOK ; Moon Ho YANG
Korean Journal of Pathology 1988;22(3):336-339
The authors report a case of ectopic paragonimiasis in a 33 year old Korean housewife who came to the hospital because of lower abdominal discomfortness and palpable mass. Parasitic granulomas involved the ovary and posterior wall of the uterine body. This report deals with the rare occurrence of a parasitic infestation in the ovary.